The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.16 (6.557%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.52
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM and Board Reappointments

28 Sep 2021 10:55

RNS Number : 2247N
Globalworth Real Estate Inv Ltd
28 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

28 September 2021

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Results of AGM and Board Reappointments

Results of Annual General Meeting 

The Board of Directors of the Company is pleased to announce that, at the annual general meeting of the Company held on Tuesday 28 September 2021, all the resolutions relating to both the ordinary business and the special business were duly passed by shareholders. Votes were as follows: 

 

1.

IT WAS RESOLVED that the Company's annual report and audited financial statements for the year ended 31 December 2020, together with the directors' and auditor's reports thereon, be received and adopted.

(191,206,846 votes cast, all in favour, none against and none withheld).

2.

IT WAS RESOLVED that Ernst & Young Cyprus Limited be re-appointed as auditor of the Company.

(191,206,846 votes cast, all in favour, none against and none withheld).

3.

 

IT WAS RESOLVED that the Directors be authorised to agree the auditor's remuneration.

(191,206,846 votes cast, all in favour, none against and none withheld).

4.

IT WAS RESOLVED that Mr David Maimon be re-appointed as a director.

(191,206,846 votes cast, 190,523,761 in favour, 683,085 against and none withheld).

5.

IT WAS RESOLVED that in replacement of all previous authorities, the Company be authorised, in accordance with section 315(1)(a) of The Companies (Guernsey) Law, 2008, as amended (the "Law"), to make market acquisitions (within the meaning of section 316 of the Law) of ordinary shares in the capital of the Company on the terms set out in the notice of the AGM.

(191,206,846 votes cast, all in favour, none against and none withheld).

6.

IT WAS RESOLVED that the Directors be authorised to exercise an Acquisition Share Authority in respect of 16,619,173 Shares on the terms set out in the notice of the AGM.

(191,206,846 votes cast, all in favour, none against and none withheld).

7.

IT WAS RESOLVED that the Directors be authorised to issue up to 147,725,979 Shares on the terms set out in the notice of the AGM.

(191,206,846 votes cast, all in favour, none against and none withheld).

8.

IT WAS RESOLVED that the provisions relating to pre-emption rights enshrined in Article 5 of the Articles be disapplied in respect of up to 16,619,173 Shares, provided that this authority shall be limited by the terms set out in the notice of the AGM.

(191,206,846 votes cast, 190,523,761 in favour, 683,085 against and none withheld).

 

Board Reappointments

 

As previously announced, Resolutions regarding the annual re-elections of Geoff Miller, John Whittle and Andreea Petreanu were not included in this year's Notice of AGM. Instead, immediately following the AGM, they have been re-appointed by the Board for an interim period, pending confirmation of anticipated changes to Globalworth's Board in order to reflect the Consortium's (CPI Property Group S.A. and Aroundtown SA through their indirect ownership of Zakiono) majority shareholding in Globalworth. Further information regarding the long-term composition of the Board will be provided in due course.

 

For further information visit www.globalworth.com or contact:

Enquiries

Stamatis Sapkas

Deputy Chief Investment Officer

Tel: +40 732 800 000

Jefferies (Joint Broker)

Stuart Klein

Tel: +44 20 7029 8000

Panmure Gordon (Nominated Adviser and Joint Broker)

Alina Vaskina

Tel: +44 20 7886 2500

 

About Globalworth / Note to Editors:

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Poland and Romania. Globalworth acquires, develops and directly manages high-quality office and industrial real estate assets in prime locations, generating rental income from high quality tenants from around the globe. Managed by over 230 professionals across Cyprus, Guernsey, Poland and Romania, a combined value of its portfolio is €3.1 billion, as at 30 June 2021. Approximately 95.1% of the portfolio is in income-producing assets, predominately in the office sector, and leased to a diversified array of over 650 national and multinational corporates. In Poland Globalworth is present in Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice, while in Romania its assets span Bucharest, Timisoara, Constanta and Pitesti. For more information, please visit www.globalworth.com and follow us on Facebook, Instagram and LinkedIn.

IMPORTANT NOTICE: This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom. This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEANNPASAFEEA
Date   Source Headline
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM
1st Jun 20224:20 pmRNSEUR85 million loan agreement with the IFC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.